Deutsche Beteiligungs — Investments picked up in Q225, exits still muted

Deutsche Beteiligungs (FRA: DBAN)

Last close As at 12/08/2025

EUR24.50

−0.10 (−0.41%)

Market capitalisation

EUR461m

More on this equity

Research: Investment Companies

Deutsche Beteiligungs — Investments picked up in Q225, exits still muted

Deutsche Beteiligungs (DBAG) posted a 1.9% NAV total return (TR) in H125, with the positive impact of higher valuation multiples partly offset by a negative contribution from portfolio earnings growth and higher portfolio net debt. DBAG delivered on its promise of a pick-up in investment activity, with three private debt investments, a long-term minority investment into FinMatch (funded entirely from DBAG’s balance sheet) and a follow-on private equity (PE) investment in an existing portfolio company. Consequently, DBAG considers itself fully invested. Exits proved more difficult to complete in the current environment than expected, with management now assuming at least one realisation by the end of the year (compared to three to four exits expected until Q126 at the time of the Q125 results release). DBAG’s shares now trade at a wide 30.3% discount to the last reported NAV of its private market investments, on top of which DBAG’s shares offer exposure to its fund services business, generating recurring earnings (guided at €10–15m in FY25).

Milosz Papst

Written by

Milosz Papst

Director of Content, Investment Trusts

Investment companies

Listed private equity

13 August 2025

Price €24.55
Market cap €463m
Shares in issue 17.8m
Code/ISIN DBAN/DE000A1TNUT7
Primary exchange FSE
AIC sector N/A
Financial year end 31 December
52-week high/low €26.5 €20.0

Fund objective

Deutsche Beteiligungs is a German-based and listed private equity investment and fund management company that invests in mid-sized companies in Germany and neighbouring countries via management buyout transactions and growth capital financings. It also manages c €2bn of third-party capital, which generates stable recurring fee income. Following the acquisition of a majority stake in ELF Capital, it expanded its offer to include private debt.

Bull points

  • Solid long-term track record, with an average private equity exit multiple of 2.5x at end-FY24.
  • Emphasis on ‘growth sectors’ such as IT services and software, energy transition/sustainability themes and healthcare.
  • Recurring cash flow from fund services.

Bear points

  • Continued impact from the weak macroeconomic environment in Germany, especially on DBAG’s industrial holdings.
  • Interest rate normalisation may reduce prospective private equity returns, put pressure on interest coverage ratios and/or lead to refinancing issues across private equity-backed companies in the medium term.
  • Higher average leverage of portfolio companies versus pre-COVID-19 levels.

Analyst

Milosz Papst
+44 (0)20 3077 5700

Deutsche Beteiligungs is a research client of Edison Investment Research Limited

German order books weak, but fiscal boost ahead

Sentiment towards German equities improved markedly this year on the back of parliamentary elections, the announcement of the €500bn infrastructure fund and the relaxation of the ‘debt brake’ rule to exempt defence spending of more than 1% of GDP. While economic growth in Germany is constrained by the lack of sufficient new orders, fiscal stimulus should provide tailwinds to growth, especially from 2026 when the ifo Institute expects GDP growth of 1.5% (vs 0.3% in 2025). The US-EU tariff deal provided some clarity, albeit the new 15% tariffs will limit growth (the Kiel Institute estimates the short-term impact at 0.13pp of GDP growth).

Proceeds from convertible bond issue fully deployed

DBAG’s recent investments, coupled with the latest €1.25 dividend per share (paid for FY24 and the abbreviated year to end-December 2024) and share buybacks (a €20m programme is ongoing) allowed it to fully deploy the proceeds of its €100m convertible bond issue completed in 2024 and subsequent exits. DBAG’s end-June 2025 liquidity consists of €39m of financial resources and €92m of undrawn credit facility (with €35m drawn). This excludes €30m of investments made after the reporting date. We also note four add-on acquisitions completed across its portfolio in H125, with congatec’s acquisition of its competitor JUMPtec the most significant.

NAV TR at 1.9% in H125 driven by higher multiples

DBAG’s NAV was broadly flat in total return terms in Q225, bringing its H125 performance to 1.9% on the back of a €34.1m contribution from the change in multiples across sectors (see Exhibit 1), most notably for companies with business models related to the manufacturing industry. This came from a combination of the investment case’s strong progress in two portfolio holdings (warranting a higher multiple, according to DBAG), the revaluation of some assets as a result of bids DBAG received and the positive development of public markets (which is adjusted by DBAG’s private market factor, see our May 2024 note for background). The German public market benefited from a revival in investor sentiment across the market cap spectrum (see Exhibit 2) due to the factors described above. The contribution from earnings remained negative at €6.7m, while higher net debt reduced valuations by €7.4m. The share of portfolio companies with net debt to EBITDA of 3.0x or more improved slightly to 51% at end-June 2025 from 52% at end-2024, mostly due to expected EBITDA growth slightly outpacing the debt increase at these companies, as well as mix effects.

Earnings growth constrained by a low level of new orders...

The outlook for a potential inflection point across DBAG’s portfolio (which management communicated at the beginning of 2025) was dampened by the US tariff turmoil. Management considers its portfolio well-protected against the first-order impact of US tariffs (which as per the final deal were set at 15% versus the initially announced 30%), with only 10% of holdings directly affected. Nevertheless, it was affected by second-order effects, resulting in reduced order intake, which is a broader issue across Germany. According to a business survey released on 8 August by the ifo Institute, 36.7% of companies in Germany are experiencing an insufficient level of new orders, a slight improvement compared to 37.3% in April but well above the long-term average. Sectors particularly affected are automotive (42.6%), mechanical engineering (46.1%) and manufacturers of electrical equipment (40.6%). That said, there were selected DBAG holdings with a positive contribution from earnings growth in the IT services & software, as well as the industrial and industrial technology sectors, among others.

...but fiscal stimulus should provide tailwinds from 2026

In its Economic Forecast Summer 2025 report (published in June 2025), the ifo Institute said that the crisis in the German economy reached its low point in the winter half-year 2024/25. While it estimates that around half of the 0.4% GDP growth in Q125 versus the previous quarter was due to exports to the US being front-loaded ahead of US tariffs, growth was supported by investments, as well as private consumption (which has seen positive development for several quarters, with an accelerating trend). The ifo forecasts that Germany’s real GDP will grow by 0.3% in 2025 and 1.5% in 2026, with a significantly greater boost to economic growth from Germany’s fiscal policy in 2026. In this context, the institute highlighted several proposed fiscal measures beyond the above-mentioned infrastructure and defence spending, including tax incentives such as accelerated depreciation, a VAT reduction for the hospitality sector, electricity tax and grid fees, as well as a higher commuter allowance. The German Bundesbank was more cautious in its June forecast with respect to the timing of an economic revival, expecting stagnant GDP in 2025, followed by 0.7% growth in 2026 and 1.2% growth in 2027. The Bundesbank’s president believes Germany’s public finances can cope with a temporary increase in the deficit and debt ratios (which the Bundesbank forecasts at just over 4% and 66% by 2027, respectively). The US-EU tariff deal on 27 July provided some clarity, although the 15% tariff rate will be a significant drag for German industrial companies, including the automotive sector (although in the latter case, lower than the pre-deal 27.5% tariff). The Kiel Institute estimates the negative impact of the US tariffs at 0.13pp of annual GDP growth.

Portfolio exits below previous management expectations

The demanding macro environment, which weighed on DBAG’s value creation and exit processes, led management to adjust its NAV per share guidance for FY25 to €35–38 (from €36–43 previously). DBAG’s management highlighted that there is a particular safety margin in terms of public market valuations embedded in this guidance and a 7% pull-back of public equities would not require a revision of this guidance. At the time of releasing the Q125 results in May 2025, DBAG’s management communicated its expectation for three to four exits until Q126 (skewed towards H225/Q126), despite elevated macroeconomic and geopolitical uncertainty. However, the exit environment has proved more challenging and DBAG now assumes at least one exit by the end of the year. Management highlighted that completing one or two exits this year would potentially allow DBAG to reach the upper end of its NAV per share guidance.

The more muted exit activity resulted in a higher level of assets under management for its DBAG funds than originally expected, and in turn €24.1m in income and €7.1m EBITA from its fund services business in H125. Therefore, DBAG’s management raised its FY25 guidance for fund services EBITA to €10–15m from €8–13m previously. H125 income was broadly flat year-on-year, while EBITA fell by 21% y-o-y, mostly due to overall lower income from advisory services and higher personnel expenses, the latter partly driven by capacity addition ahead of the fund-raising for DBAG’s new flagship buyout fund (despite a decline in fixed compensation in the absence of inflation compensation bonuses, similar to last year). Management previously expected the new fund to launch towards summer 2026 with a size slightly above €1bn (ie similar to its predecessor).

DBAG is fully invested following recent capital deployment

In line with the expectations management expressed during the Q125 results call in May, the pace of DBAG’s capital deployment has accelerated recently, with €66.6m invested in three private debt transactions and €29.5m in private equity investments. Overall, to date, DBAG has invested €83m in four private debt transactions via ELF Capital funds (with all being senior secured debt) across a diverse set of industries. Its first deal (completed in August 2024) involved refinancing an existing loan and providing growth financing for an Irish manufacturer of generic drugs. In February 2025, DBAG agreed to finance the acquisition of a company specialising in passive electronic components for a global blue-chip customer base. In June 2025, it agreed two transactions, one supporting a family office in creating a digital and physical marketing asset production platform via the acquisition of two assets, and the other financing the combination of three fintech businesses catering to international students in Germany. As a result, the share of private debt investments in DBAG’s portfolio increased to c 10% and has already reached the lower end of its 10–20% target range. DBAG’s management aims to reach 15–20% with more transactions to come, but at a slower pace of capital deployment than recently. Here, we note that DBAG’s total current commitment to ELF Capital funds stands at €100m.

These four private debt transactions offer a blended three-year gross internal rate of return of 13.8% and a money multiple of 1.39x (DBAG’s management expects an average 2.5-year maturity as a result of early repayments). One advantage of DBAG’s private debt investments is a steady income stream, which, following recent investments, is expected to more than cover the interest expense on its €100m convertible debt (which bears a fixed 5.5% coupon). The convertible bond has a conversion price of €29.3457 and is therefore out-of-the-money for now (while the conversion price is c 16.7% below end-June 2025 NAV). The bond matures in January 2030.

DBAG’s largest PE investment in H125 was a follow-on investment into an undisclosed existing portfolio company, replacing external financing, at what DBAG’s management describes as very attractive terms. Post reporting date (on 31 July), DBAG announced that it had acquired a significant minority stake in FinMatch, a digital corporate finance platform for mid-market companies with more than 1,000 financing partners, as a long-term balance sheet investment. The company’s founders will retain a majority stake. FinMatch was established in 2019 and since then has facilitated more than 750 financing projects (involving corporate loans, subsidies and grants) with a volume of more than €10bn. It focuses on businesses domiciled in the DACH region (Germany, Austria or Switzerland) with an annual turnover of at least €5m and a financing need of at least €1m. DBAG highlights that it is a high-margin business operating in an attractive and growing market. It aims to further accelerate its organic growth through platform improvements, digital channels and sector focus, among others. The transaction was structured as a preferred equity investment, giving DBAG downside protection through a liquidation preference. While ELF Capital became a financing partner on the FinMatch platform, the average ticket size is normally below the targeted deal size for ELF Capital funds, and therefore the FinMatch platform will be a deal origination channel for ELF Capital, only occasionally, for larger ‘outlier’ financings.

Following the above transactions, DBAG is fully invested; it has deployed the proceeds from the convertible bond issue and realisations (see Exhibit 4). Its financial resources (cash and short-term investments) amounted to €39m at end-June 2025, roughly equal to the €35m drawn part of its credit facility. A further €92m remains undrawn and, together with financial resources, covers 51% of DBAG’s outstanding investment commitments (which should be drawn over several years). DBAG invested a further €30m in July 2025, which includes the above-mentioned investment in FinMatch.

We also note that there were four add-on investments agreed by DBAG’s portfolio companies in H125, of which the most significant was congatec’s acquisition of JUMPtec (signed and closed in June 2025, with no incremental equity contribution from DBAG). JUMPtec (carved out from the listed company Kontron) has a similar business model to congatec, which is an industrial technology company focused on high-performance embedded computer (‘computer-on-module’ or COM) products. However, it has a bigger exposure to aerospace and defence, where congatec is under-represented, with other focus areas including electronic equipment and instruments, industrial automation and medical applications. Interestingly, congatec’s founding team includes several ex-JUMPtec/Kontron managers. According to DBAG, JUMPtec’s expected revenue for 2025 stands at $94m, which compares with congatec’s 2024 sales of €202m (or c $218m, up c 14% y-o-y) and the size of the overall COM market at $1.8bn (as stated by DBAG, broadly in line with estimates available online). DBAG highlighted that the acquisition almost doubles congatec’s market share, especially in Europe and North America. The acquisition was structured as an asset transaction, which means that congatec is not taking over JUMPtec’s overheads (making the transaction accretive from day one), while the significant business overlap allows for substantial personnel cost synergies, according to DBAG. We understand that the main objective of the acquisition was to drive scale and in turn profitability via cost synergies.

Valuation

DBAG’s NAV TR in euro terms between end-June 2020 and end-June 2025 reached 50.3%, or c 8.5% per year, which is broadly in line with the return posted by the German small-cap index (SDAX) of 8.8% per year (see Exhibit 6), although we acknowledge that institutional investors typically expect PE to outperform public equities by 300bp net of fees. Against the backdrop of a weak macroeconomic environment in Germany, DBAG’s five-year NAV TR is behind the PE peer average, although it outperformed the peer average over three years, ranking third (see Exhibit 9). Meanwhile, its share price TR decoupled from NAV performance and stood at just 7.3%, leading to a discount to last reported NAV of 30.3% currently (see Exhibit 7). We note that, before 2022, DBAG’s shares traded at a premium to NAV (18% on average over the five years to end-2021), which we believe was due to the share price reflecting the additional value of DBAG’s fund services business, which manages c €2bn of third-party capital, the value of which is not directly captured in DBAG’s reported NAV. Given this, DBAG’s portfolio changes in terms of sector exposure and the increasing share of private debt investments (which likely bear a lower risk than PE investments), the current discount to NAV may be considered wide.

We consider it instructive to examine the market-implied valuation of both DBAG segments in two scenarios: 1) using the implied value of PE investments, assuming fund services are valued in line with peers; and 2) using the implied value of the fund services segment, assuming that PE investments are valued in line with peers. For peers in DBAG’s fund services segment, we use a group of listed asset managers with exposure to alternative unlisted assets such as real assets or PE: Blackstone, EQT, Partners Group, Intermediate Capital, Tikehau Capital, Cohen & Steers and CVC Capital Partners. We acknowledge that these companies have assets under management that are an order of magnitude larger than that of DBAG, which may distort the analysis. In the case of PE investments, we use the peer group shown in Exhibit 9, excluding 3i.

Assuming the fund services segment is valued in line with peers (on a 22.6x FY25e earnings multiple) and using DBAG’s current market capitalisation, the implied value of DBAG’s PE investments would be c €154m (73% below its end-June 2025 NAV, which we conservatively adjust for the intangibles arising from the ELF Capital acquisition), while DBAG’s peers currently trade at an average 22% discount. If we conservatively assume the lower end of the peer valuation range (12.4x), we arrive at an implied value of DBAG’s PE investment of €283m, a still sizeable 51% discount to DBAG’s end-June 2025 NAV. On the other hand, if we assume that the PE investments were valued in line with peers, then DBAG’s current market capitalisation would imply a negative value for the fund services business (based on the midpoint of management’s revised FY25 guidance of €10–15m). This needs to be put in the context of management’s expectations of an increase in fund services pre-tax profit to €12–18m in FY27 on the expected launch of DBAG Fund VIII’s successor. Finally, management envisions that the successor of the €250m ECF IV fund could be larger than €300m.

General disclaimer and copyright

This report has been commissioned by Deutsche Beteiligungs and prepared and issued by Edison, in consideration of a fee payable by Deutsche Beteiligungs. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2025 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Deutsche Beteiligungs

View All

Latest from the Investment Companies sector

View All Investment Companies content

Research: Healthcare

Sareum Holdings — New collaboration cements focus on CNS

Sareum has announced a strategic collaboration with Receptor.AI, a ‘techbio’ company harnessing generative AI to accelerate drug discovery across a range of targets, including TYK2. Sareum had previously reported positive signals from early preclinical testing of six of its TYK2/JAK1 compounds, three of which showed meaningful penetration of the blood-brain barrier, including one with strong drug concentration in the brain. We see this collaboration as a logical extension of the company’s efforts in establishing JAK inhibitors (in particular TYK2) as a potentially disease-modifying treatment for neuroinflammatory conditions such as Parkinson’s disease (PD) and multiple sclerosis (MS). While Receptor.AI will focus on drug discovery (brain-penetrating, isoform-selective compounds) using its AI-powered in-silico platform, Sareum will oversee subsequent testing, with full ownership of IP rights. First results from the collaboration are expected by end CY25 and will be a key upcoming catalyst for the company. The market has reacted positively to the news, with the stock trading 9% higher at market close on 12 August.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free